PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: TrovaGene, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Researchers Focus on Novel Test to Detect Lyme Disease - TrovaGene Scientists aiming to solve mystery of accurately diagnosing the disease in bid to help curb the rising number of cases
Researchers Focus on Novel Test to Detect Lyme Disease

 

NewswireToday - /newswire/ - San Diego, CA, United States, 2010/06/02 - TrovaGene Scientists aiming to solve mystery of accurately diagnosing the disease in bid to help curb the rising number of cases. TROV.PK

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

As Lyme disease increases at an alarming pace and fears that undiagnosed cases are creating a medical iceberg, scientists are working with speed and diligence to unlock the secret to a more effective test to head off an even wider medical crisis.

The challenge is to develop a test that is not only quick and accurate, but that is so sensitive that it cannot be fooled into failing to diagnose the illness, or to misdiagnose it as something else.

Scientists at TrovaGene, Inc., (formerly Xenomics, Inc.) a developer of transrenal molecular diagnostics, are now working on a non-invasive, urine-based test to diagnose and monitor various diseases and disorders, and which company officials say can be applied to the corkscrew-shaped bacterium Borrelia burgdorferi, better known as Lyme disease, and if successful, provide the most effective test available.

“We have begun research and expect significant results in 2011,” said Thomas Adams, TrovaGene’s Board Chairman.
"The critical distinction from existing tests is that the TrovaGene technology provides a more highly-sensitive method of detection by finding and analyzing "ultra short" (20-50 base pair) nucleic acids in a urine specimen."
“Looking for these short DNA sequences should result in a highly reliable test for the disease,” said Adams.

The testing involves the collection of a urine sample from the patient, thus eliminating the need for an invasive blood drawing procedure.

Lyme disease, so coined because the initial outbreak, spread by the Deer tick, occurred near the Connecticut river town of Old Lyme. In the latest report by the Centers for Disease Control and Prevention (CDC), 28,921 people were stricken in 2008. But authorities estimate the real number could be 10 times greater because of undiagnosed, misdiagnosed or simply unreported cases.

The symptoms can include headaches, fatigue, joint pain, speech and vision impairment and sleep abnormalities. But accurately diagnosing the disease is another story.

“The disease can be effectively treated with antibiotics if properly diagnosed,” said Adams. “But it has been difficult to diagnose with current testing tools and it can be mistaken for chronic fatigue syndrome, rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Bell's palsy or even Lou Gehrig's disease (ALS)."
When people do not receive treatment because of non-or-misdiagnosis and the disease lingers in the body, that’s when the condition becomes chronic, Adams said, and the medical agony multiplies.

“We expect that with our urine analysis, results will be available within 24 hours of taking the test,” he added. “We are looking forward to our test providing a substantial breakthrough in the area of Lyme disease detection.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: TrovaGene, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Researchers Focus on Novel Test to Detect Lyme Disease

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Alex Michelini - Trovagene.com 
858-217-4838 x101 bhuebner[.]trovagene.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any TrovaGene, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From TrovaGene, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)